'Targeted & immunotherapy combination has demonstrated improved survival in RCC'

'Targeted & immunotherapy combination has demonstrated improved survival in RCC' World Kidney Cancer Day: Renal cell carcinoma (RCC) is generally resistant to traditional chemotherapy and radiation therapy. It is crucial that patients with advanced or metastatic kidney cancer receive systemic therapy that includes targeted therapy and immunotherapy. https://ift.tt/G9lg5Ho

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018